Recursion Pharmaceuticals Reports Wider-Than-Expected Q2 Loss, Beats Revenue Estimates

Benzinga
2025.08.05 16:39
portai
I'm PortAI, I can summarize articles.

Recursion 報告第二季度收入為 1922 萬美元，超出分析師預期的 1623 萬美元。Recursion 報告第二季度每股虧損 41 美分，未能達到預期的每股虧損 34 美分。市場回暖，這三隻收益股票表現良好。點擊這裏查看→

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.